bylvay
(odevixibat)Ipsen Biopharmaceuticals, Inc.
Usage: BYLVAY is indicated for treating pruritus in patients aged 3 months and older with Progressive Familial Intrahepatic Cholestasis (PFIC) and for cholestatic pruritus in patients aged 12 months and older with Alagille Syndrome (ALGS). Limitations include potential ineffectiveness in certain PFIC type 2 patients.